These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30565312)

  • 1. Enhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis.
    Ohta Y; Nomura E; Shang J; Feng T; Huang Y; Liu X; Shi X; Nakano Y; Hishikawa N; Sato K; Takemoto M; Yamashita T; Abe K
    J Neurosci Res; 2019 May; 97(5):607-619. PubMed ID: 30565312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: Implication for GSH synthesis via activating Akt/GSK3β/Nrf2/GCLC pathways.
    Zhang C; Yang Y; Liang W; Wang T; Wang S; Wang X; Wang Y; Jiang H; Feng H
    Brain Res Bull; 2019 Mar; 146():287-301. PubMed ID: 30690059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Imaging of Oxidative and Hypoxic Stresses in Mice Model of Amyotrophic Lateral Sclerosis.
    Ohta Y; Nomura E; Kizaka-Kondoh S; Abe K
    Methods Mol Biol; 2022; 2525():289-294. PubMed ID: 35836077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γ-Oryzanol mitigates oxidative stress and prevents mutant SOD1-Related neurotoxicity in Drosophila and cell models of amyotrophic lateral sclerosis.
    Zhang C; Liang W; Wang H; Yang Y; Wang T; Wang S; Wang X; Wang Y; Feng H
    Neuropharmacology; 2019 Dec; 160():107777. PubMed ID: 31521619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1
    Yang B; Pan J; Zhang XN; Wang H; He L; Rong X; Li X; Peng Y
    Neurobiol Dis; 2023 Aug; 184():106210. PubMed ID: 37352984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edaravone for the treatment of amyotrophic lateral sclerosis.
    Yoshino H
    Expert Rev Neurother; 2019 Mar; 19(3):185-193. PubMed ID: 30810406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-enhanced brain delivery of edaravone provides additive amelioration on disease progression in an ALS mouse model.
    Shen Y; Zhang J; Xu Y; Sun S; Chen K; Chen S; Yang X; Chen X
    Brain Stimul; 2023; 16(2):628-641. PubMed ID: 36931463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice.
    Ito H; Wate R; Zhang J; Ohnishi S; Kaneko S; Ito H; Nakano S; Kusaka H
    Exp Neurol; 2008 Oct; 213(2):448-55. PubMed ID: 18718468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis.
    Neymotin A; Calingasan NY; Wille E; Naseri N; Petri S; Damiano M; Liby KT; Risingsong R; Sporn M; Beal MF; Kiaei M
    Free Radic Biol Med; 2011 Jul; 51(1):88-96. PubMed ID: 21457778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients.
    Park JM; Kim SY; Park D; Park JS
    Neurol Sci; 2020 Jan; 41(1):119-123. PubMed ID: 31471712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1α/Nrf2/HO-1 pathway in ALS mice.
    Wen J; Li S; Zheng C; Wang F; Luo Y; Wu L; Cao J; Guo B; Yu P; Zhang G; Li S; Sun Y; Yang X; Zhang Z; Wang Y
    Neuropharmacology; 2021 Jan; 182():108380. PubMed ID: 33152451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
    Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
    Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging Hypoxic Stress and the Treatment of Amyotrophic Lateral Sclerosis with Dimethyloxalylglycine in a Mice Model.
    Nomura E; Ohta Y; Tadokoro K; Shang J; Feng T; Liu X; Shi X; Matsumoto N; Sasaki R; Tsunoda K; Sato K; Takemoto M; Hishikawa N; Yamashita T; Kuchimaru T; Kizaka-Kondoh S; Abe K
    Neuroscience; 2019 Sep; 415():31-43. PubMed ID: 31344397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edaravone May Prevent Ferroptosis in ALS.
    Spasić S; Nikolić-Kokić A; Miletić S; Oreščanin-Dušić Z; Spasić MB; Blagojević D; Stević Z
    Curr Drug Targets; 2020; 21(8):776-780. PubMed ID: 32077821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS.
    Kanno T; Tanaka K; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Hirayama N; Ikeda JE
    Free Radic Biol Med; 2012 Dec; 53(11):2028-42. PubMed ID: 23000247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse.
    Ikeda K; Iwasaki Y
    PLoS One; 2015; 10(10):e0140316. PubMed ID: 26469273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis.
    Petri S; Kiaei M; Kipiani K; Chen J; Calingasan NY; Crow JP; Beal MF
    Neurobiol Dis; 2006 Apr; 22(1):40-9. PubMed ID: 16289867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edaravone Reduces Iron-Mediated Hydrocephalus and Behavioral Disorder in Rat by Activating the Nrf2/HO-1 Pathway.
    Zhang J; Shi X; Chen Z; Geng J; Wang Y; Feng H; Zhu G; Chen Q
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3511-3520. PubMed ID: 30205995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
    Feng X; Peng Y; Liu M; Cui L
    Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.